EDITORIALS

Hypoxia Response Pathways and Radiotherapy for Head and Neck Cancer

Jean Bourhis

JCO Feb 10 2006: 725–726. First published on Jan 17 2006; 10.1200/JCO.2005.04.5146. [Full Text] [PDF]

ORIGINAL REPORTS
Head and Neck Cancer
	Endogenous Markers of Two Separate Hypoxia Response Pathways (hypoxia inducible factor 2 alpha and carbonic anhydrase 9) Are Associated With Radiotherapy Failure in Head and Neck Cancer Patients Recruited in the CHART Randomized Trial
	Michael I. Koukourakis, Søren M. Bentzen, Alexandra Giatromanolaki, George D. Wilson, Frances M. Daley, Michele I. Saunders, Stanley Dische, Efthimios Sivridis, and Adrian L. Harris
	JCO Feb 10 2006: 727–735. First published on Jan 17 2006; 10.1200/JCO.2005.02.7474. [Abstract] [Full Text] [PDF]
	Molecular Classification Identifies a Subset of Human Papillomavirus–Associated Oropharyngeal Cancers With Favorable Prognosis
	Paul M. Weinberger, Ziwei Yu, Bruce G. Haffty, Diane Kowalski, Malini Harigopal, Janet Brandsma, Clarence Sasaki, John Joe, Robert L. Camp, David L. Rimm, and Amanda Psyrri
	JCO Feb 10 2006: 736–747. First published on Jan 9 2006; 10.1200/JCO.2004.00.3335. [Abstract] [Full Text] [PDF]

Gastrointestinal Cancer
	Association of Activated Transcription Factor Nuclear Factor B With Chemoradiation Resistance and Poor Outcome in Esophageal Carcinoma
	Julie G. Izzo, Usha Malhotra, Tsung-Teh Wu, Joe Ensor, Rajyalakshmi Luthra, Jeffrey H. Lee, Stephen G. Swisher, Zhongxing Liao, K.S. Clifford Chao, Walter N. Hittelman, Bharat B. Aggarwal, and Jaffer A. Ajani
	JCO Feb 10 2006: 748–754. First published on Jan 9 2006; 10.1200/JCO.2005.03.8810. [Abstract] [Full Text] [PDF]

Gynecologic Cancer
	Preoperative Serum Tissue Factor Levels Are an Independent Prognostic Factor in Patients With Ovarian Carcinoma
	Liz Y. Han, Charles N. Landen, Jr, Aparna A. Kamat, Adriana Lopez, David P. Bender, Peter Mueller, Rosemarie Schmandt, David M. Gershenson, and Anil K. Sood
	JCO Feb 10 2006: 755–761. First published on Dec 27 2005; 10.1200/JCO.2005.02.9181. [Abstract] [Full Text] [PDF]
	Antibody Immunity to the p53 Oncogenic Protein Is a Prognostic Indicator in Ovarian Cancer
	Vivian Goodell, Lupe G. Salazar, Nicole Urban, Charles W. Drescher, Heidi Gray, Ron E. Swensen, Martin W. McIntosh, and Mary L. Disis
	JCO Feb 10 2006: 762–768. First published on Jan 3 2006; 10.1200/JCO.2005.03.2813. [Abstract] [Full Text] [PDF]

Breast Cancer
	Antiangiogenic and Antitumor Effects of Bevacizumab in Patients With Inflammatory and Locally Advanced Breast Cancer
	Suparna Bonthala Wedam, Jennifer A. Low, Sherry X. Yang, Catherine K. Chow, Peter Choyke, David Danforth, Stephen M. Hewitt, Arlene Berman, Seth M. Steinberg, David J. Liewehr, Jonathan Plehn, Arpi Doshi, Dave Thomasson, Nicole McCarthy, Hartmut Koeppen, Mark Sherman, JoAnne Zujewski, Kevin Camphausen, Helen Chen, and Sandra M. Swain
	JCO Feb 10 2006: 769–777. First published on Jan 3 2006; 10.1200/JCO.2005.03.4645. [Abstract] [Full Text] [PDF]

Genitourinary Cancer
	Defining Molecular Profiles of Poor Outcome in Patients With Invasive Bladder Cancer Using Oligonucleotide Microarrays
	Marta Sanchez-Carbayo, Nicholas D. Socci, Juanjo Lozano, Fabien Saint, and Carlos Cordon-Cardo
	JCO Feb 10 2006: 778–789. First published on Jan 23 2006; 10.1200/JCO.2005.03.2375. [Abstract] [Full Text] [PDF] [Supplementary Data]

Hematologic Malignancies
	BAALC Expression and FLT3 Internal Tandem Duplication Mutations in Acute Myeloid Leukemia Patients With Normal Cytogenetics: Prognostic Implications
	Claudia D. Baldus, Christian Thiede, Silke Soucek, Clara D. Bloomfield, Eckhard Thiel, and Gerhard Ehninger
	JCO Feb 10 2006: 790–797. First published on Jan 17 2006; 10.1200/JCO.2005.01.6253. [Abstract] [Full Text] [PDF]

Melanoma
	Serum YKL-40 Predicts Relapse-Free and Overall Survival in Patients With American Joint Committee on Cancer Stage I and II Melanoma
	Henrik Schmidt, Julia S. Johansen, Pia Sjoegren, Ib J. Christensen, Boe S. Sorensen, Kirsten Fode, Jorn Larsen, and Hans von der Maase
	JCO Feb 10 2006: 798–804. First published on Jan 3 2006; 10.1200/JCO.2005.03.7960. [Abstract] [Full Text] [PDF]

Molecular Oncology
	TAp73 Upregulation Correlates With Poor Prognosis in Human Tumors: Putative In Vivo Network Involving p73 Isoforms, p53, and E2F-1
	Gemma Domínguez, José M. García, Cristina Peña, Javier Silva, Vanesa García, Lara Martínez, Constanza Maximiano, María E. Gómez, José A. Rivera, Carmen García-Andrade, and Felix Bonilla
	JCO Feb 10 2006: 805–815. First published on Dec 27 2005; 10.1200/JCO.2005.02.2350. [Abstract] [Full Text] [PDF]

Pediatric Oncology
	Subtype and Prognostic Classification of Rhabdomyosarcoma by Immunohistochemistry
	Marco Wachtel, Tina Runge, Ivo Leuschner, Sabine Stegmaier, Ewa Koscielniak, Jörn Treuner, Bernhard Odermatt, Silvia Behnke, Felix K. Niggli, and Beat W. Schäfer
	JCO Feb 10 2006: 816–822. First published on Jan 3 2006; 10.1200/JCO.2005.03.4934. [Abstract] [Full Text] [PDF]

REVIEW ARTICLE
	Antibody Pretargeting Advances Cancer Radioimmunodetection and Radioimmunotherapy
	David M. Goldenberg, Robert M. Sharkey, Giovanni Paganelli, Jacques Barbet, and Jean-François Chatal
	JCO Feb 10 2006: 823–834. First published on Dec 27 2005; 10.1200/JCO.2005.03.8471. [Abstract] [Full Text] [PDF]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.